Iodide

Iodide

SCHEMBL174548

CC1CNCCc2ccccc21.I

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 17/20 0.96
HTR2A P28223 14/20 0.96
HTR2B P41595 13/20 0.96
ADRB1 P08588 1/20 0.60
HTR1A P08908 1/20 0.60
ADRA2A P08913 1/20 0.60
ADRA2B P18089 1/20 0.60
ADRA2C P18825 1/20 0.60
CNR1 P21554 1/20 0.60
SLC6A2 P23975 1/20 0.60
SLC6A4 P31645 1/20 0.60
HRH1 P35367 1/20 0.60
KCNH2 Q12809 1/20 0.60
TAAR1 Q96RJ0 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL164205 0.98 HTR2C (1.00) HTR2CHTR2AHTR2BADRB1HTR1A
Bromide SCHEMBL174576 0.96 HTR2C (0.96) HTR2CHTR2AHTR2BADRB1HTR1A
Hydrochloric Acid SCHEMBL174589 0.96 HTR2C (0.96) HTR2CHTR2AHTR2BADRB1HTR1A
Water SCHEMBL16465743 0.96 HTR2C (0.96) HTR2CHTR2AHTR2BADRB1HTR1A
Hydrochloric Acid SCHEMBL175003 0.95 HTR2C (0.93) HTR2CHTR2AHTR2BADRB1HTR1A
Hydrochloric Acid SCHEMBL175004 0.95 HTR2C (0.93) HTR2CHTR2AHTR2BADRB1HTR1A
Phosphoric Acid SCHEMBL174885 0.89 HTR2C (0.81) HTR2CHTR2AHTR2BADRB1HTR1A
Sulfuric Acid SCHEMBL174315 0.89 HTR2C (0.81) HTR2CHTR2AHTR2BADRB1HTR1A
Glycolic Acid SCHEMBL173573 0.85 HTR2C (0.74) HTR2CHTR2AHTR2BADRB1HTR1A
Maleic Acid SCHEMBL174415 0.85 HTR2C (0.74) HTR2CHTR2AHTR2BADRB1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611449-A1 ADMINISTRATION OF LORCASERIN TO INDIVIDUALS WITH RENAL IMPAIRMENT Arena Pharmaceuticals, Inc. (US) 2013-07-10 EP disclosed
EP-2611427-A2 MODIFIED-RELEASE DOSAGE FORMS OF 5-HT2C AGONISTS USEFUL FOR WEIGHT MANAGEMENT& xA; Arena Pharmaceuticals, Inc. (US) 2013-07-10 EP disclosed
WO-2012030927-A2 MODIFIED-RELEASE DOSAGE FORMS OF 5-HT2C AGONISTS USEFUL FOR WEIGHT MANAGEMENT ARENA PHARMACEUTICALS, INC. (US) 2012-03-08 WO disclosed
WO-2012030939-A1 ADMINISTRATION OF LORCASERIN TO INDIVIDUALS WITH RENAL IMPAIRMENT ARENA PHARMACEUTICALS, INC. (US) 2012-03-08 WO disclosed